Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

BLAST: Blinatumomab for minimal residual disease in patients with ALL

Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy
BLAST: Blinatumomab for minimal residual disease in patients with ALL ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )
23 Jan 2020

The new era of ALL treatment

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
The new era of ALL treatment ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
23 Jan 2020

Safety considerations for inotuzumab in patients with relapsed/refractory ALL

Prof David Marks - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Safety considerations for inotuzumab in patients with relapsed/refractory ALL ( Prof David Marks - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
23 Jan 2020

HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer

Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020

Novel therapeutic approaches in B-progenitor ALL

Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA
Novel therapeutic approaches in B-progenitor ALL ( Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Latest concepts in frontline therapy for paediatric ALL

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Latest concepts in frontline therapy for paediatric ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Recognising the value of European cancer nurses

Prof Daniel Kelly - Cardiff University, Cardiff, UK
Recognising the value of European cancer nurses ( Prof Daniel Kelly - Cardiff University, Cardiff, UK )
13 Jan 2020

Improvements in patient safety: Encouraging patient-reporting of symptoms

Dr Catherine Oakley - Guy's and St Thomas' NHS Foundation Trust, London, UK
Improvements in patient safety: Encouraging patient-reporting of symptoms ( Dr Catherine Oakley - Guy's and St Thomas' NHS Foundation Trust, London, UK )
13 Jan 2020

Improving cancer care in the UK

Dr Becks Fisher - The Health Foundation, London, UK
Improving cancer care in the UK ( Dr Becks Fisher - The Health Foundation, London, UK )
13 Jan 2020

Dasatinib vs imatinib in the treatment of paediatric ALL

Dr Shuhong Shen - National Children's Medical Center, Shanghai, China
Dasatinib vs imatinib in the treatment of paediatric ALL ( Dr Shuhong Shen - National Children's Medical Center, Shanghai, China )
24 Dec 2019

Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients

Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
24 Dec 2019

Is enasidenib plus azacitidine better than with azacitidine alone for AML patients?

Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA
Is enasidenib plus azacitidine better than with azacitidine alone for AML patients? ( Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA )
24 Dec 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation